THDBH130

N/A

Report date: 2022/11/21 20:00:38
NME

Base Information

Drug NameTHDBH130
Drug Alias NameTHDBH130THDB130THDB131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUric acid transporter 1 inhibitors
TargetsUric acid transporter 1
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuxi Apptec(Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesMedshine Discovery IncTonghua Dongbao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperuricemiaGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A